Back to Journals » Therapeutics and Clinical Risk Management » Volume 8

Review

Interest in paromomycin for the treatment of visceral leishmaniasis (kala-azar)

       
Total article views   HTML views PDF downloads Totals
16,592 Dovepress* 10,355+ 2,297 12,652
PubMed Central* 6,237 669 6,906
Totals 16,592 2,966 19,558
*Since 22 June 2012
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 0 2

View citations on PubMed and Google Scholar